Progression from external pilot to definitive randomised controlled trial: a methodological review of progression criteria reporting

被引:16
|
作者
Mellor, Katie [1 ]
Eddy, Saskia [2 ]
Peckham, Nicholas [1 ]
Bond, Christine M. [3 ]
Campbell, Michael J. [4 ]
Lancaster, Gillian A. [5 ,6 ]
Thabane, Lehana [7 ]
Eldridge, Sandra M. [2 ]
Dutton, Susan J. [1 ]
Hopewell, Sally [1 ]
机构
[1] Univ Oxford, Ctr Stat Med, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England
[2] Queen Mary Univ London, Barts & London Sch Med & Dent, Inst Populat Hlth Sci, London, England
[3] Univ Aberdeen, Inst Appl Hlth Sci, Aberdeen, Scotland
[4] Univ Sheffield, Sch Hlth & Related Res, Sheffield, S Yorkshire, England
[5] Keele Univ, Sch Med, Keele, Staffs, England
[6] Keele Univ, Keele Clin Trials Unit CTU, Keele, Staffs, England
[7] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada
来源
BMJ OPEN | 2021年 / 11卷 / 06期
基金
英国医学研究理事会;
关键词
statistics & research methods; protocols & guidelines; clinical trials;
D O I
10.1136/bmjopen-2020-048178
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives Prespecified progression criteria can inform the decision to progress from an external randomised pilot trial to a definitive randomised controlled trial. We assessed the characteristics of progression criteria reported in external randomised pilot trial protocols and results publications, including whether progression criteria were specified a priori and mentioned in prepublication peer reviewer reports. Study design Methodological review. Methods We searched four journals through PubMed: British Medical Journal Open, Pilot and Feasibility Studies, Trials and Public Library of Science One. Eligible publications reported external randomised pilot trial protocols or results, were published between January 2018 and December 2019 and reported progression criteria. We double data extracted 25% of the included publications. Here we report the progression criteria characteristics. Results We included 160 publications (123 protocols and 37 completed trials). Recruitment and retention were the most frequent indicators contributing to progression criteria. Progression criteria were mostly reported as distinct thresholds (eg, achieving a specific target; 133/160, 83%). Less than a third of the planned and completed pilot trials that included qualitative research reported how these findings would contribute towards progression criteria (34/108, 31%). The publications seldom stated who established the progression criteria (12/160, 7.5%) or provided rationale or justification for progression criteria (44/160, 28%). Most completed pilot trials reported the intention to proceed to a definitive trial (30/37, 81%), but less than half strictly met all of their progression criteria (17/37, 46%). Prepublication peer reviewer reports were available for 153/160 publications (96%). Peer reviewer reports for 86/153 (56%) publications mentioned progression criteria, with peer reviewers of 35 publications commenting that progression criteria appeared not to be specified. Conclusions Many external randomised pilot trial publications did not adequately report or propose prespecified progression criteria to inform whether to proceed to a future definitive randomised controlled trial.
引用
收藏
页数:12
相关论文
共 23 条
  • [1] Informing efficient randomised controlled trials: exploration of challenges in developing progression criteria for internal pilot studies
    Avery, Kerry N. L.
    Williamson, Paula R.
    Gamble, Carrol
    Francischetto, Elaine O'Connell
    Metcalfe, Chris
    Davidson, Peter
    Williams, Hywel
    Blazeby, Jane M.
    BMJ OPEN, 2017, 7 (02):
  • [2] Status, reporting completeness and methodological quality of pilot randomised controlled trials in acupuncture: protocol for a systematic review
    Zhang, Yajun
    Hu, Hantong
    Li, Xiaoyu
    Lou, Jiali
    He, Xiaofen
    Jiang, Yongliang
    Fang, Jianqiao
    BMJ OPEN, 2021, 11 (12):
  • [3] REporting quality of PilOt randomised controlled trials in surgery (REPORTS): a methodological survey protocol
    McKechnie, Tyler
    Kazi, Tania
    Wang, Austine
    Zhang, Sophia
    Thabane, Alex
    Nanji, Keean
    Doumouras, Aristithes G.
    Eskicioglu, Cagla
    Thabane, Lehana
    Parpia, Sameer
    Bhandari, Mohit
    BMJ OPEN, 2024, 14 (04):
  • [4] Has the reporting quality of published randomised controlled trial protocols improved since the SPIRIT statement? A methodological study
    Tan, Zet Wei
    Tan, Aidan Christopher
    Li, Tom
    Harris, Ian
    Naylor, Justine M.
    Siebelt, Michiel
    van Tiel, Jasper
    Pinheiro, Marina
    Harris, Laura
    Chamberlain, Kira
    Adie, Sam
    BMJ OPEN, 2020, 10 (08):
  • [5] An Investigation of the Shortcomings of the CONSORT 2010 Statement for the Reporting of Group Sequential Randomised Controlled Trials: A Methodological Systematic Review
    Stevely, Abigail
    Dimairo, Munyaradzi
    Todd, Susan
    Julious, Steven A.
    Nicholl, Jonathan
    Hind, Daniel
    Cooper, Cindy L.
    PLOS ONE, 2015, 10 (11):
  • [6] Current practice in analysing and reporting binary outcome data—a review of randomised controlled trial reports
    Ines Rombach
    Ruth Knight
    Nicholas Peckham
    Jamie R. Stokes
    Jonathan A. Cook
    BMC Medicine, 18
  • [7] The reporting of progression criteria in protocols of pilot trials designed to assess the feasibility of main trials is insufficient: a meta-epidemiological study
    Mbuagbaw, Lawrence
    Kosa, Sarah Daisy
    Lawson, Daeria O.
    Stalteri, Rosa
    Olaiya, Oluwatobi R.
    Alotaibi, Ahlam
    Thabane, Lehana
    PILOT AND FEASIBILITY STUDIES, 2019, 5 (01)
  • [8] Current practice in analysing and reporting binary outcome data-a review of randomised controlled trial reports
    Rombach, Ines
    Knight, Ruth
    Peckham, Nicholas
    Stokes, Jamie R.
    Cook, Jonathan A.
    BMC MEDICINE, 2020, 18 (01)
  • [9] Atorvastatin for prevention of disease progression and hospitalisation in liver cirrhosis: protocol for a randomised, double-blind, placebo-controlled trial
    Kimer, Nina
    Gronbaek, Henning
    Fred, Rikard Goran
    Hansen, Torben
    Deshmukh, Atul Shahaji
    Mann, Mathias
    Bendtsen, Flemming
    BMJ OPEN, 2020, 10 (01):
  • [10] Sample size requirements to estimate key design parameters from external pilot randomised controlled trials: a simulation study
    Teare, M. Dawn
    Dimairo, Munyaradzi
    Shephard, Neil
    Hayman, Alex
    Whitehead, Amy
    Walters, Stephen J.
    TRIALS, 2014, 15